Julie Jordan - 03 Aug 2023 Form 4 Insider Report for Homology Medicines, Inc. (QTTB)

Signature
/s/ Paul Alloway, Attorney-in-Fact for Julie Jordan
Issuer symbol
QTTB
Transactions as of
03 Aug 2023
Net transactions value
-$2,576
Form type
4
Filing time
07 Aug 2023, 21:39:25 UTC
Previous filing
04 Aug 2023
Next filing
18 Jan 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FIXX Common Stock Options Exercise $0 +1,548 +56% $0.000000 4,318 03 Aug 2023 Direct F1
transaction FIXX Common Stock Sale $606 -436 -10% $1.39 3,882 03 Aug 2023 Direct F2
transaction FIXX Common Stock Options Exercise $0 +387 +10% $0.000000 4,269 03 Aug 2023 Direct F1
transaction FIXX Common Stock Sale $152 -109 -2.6% $1.39 4,160 03 Aug 2023 Direct F2
transaction FIXX Common Stock Options Exercise $0 +4,644 +112% $0.000000 8,804 03 Aug 2023 Direct F1
transaction FIXX Common Stock Sale $1,818 -1,308 -15% $1.39 7,496 03 Aug 2023 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FIXX Restricted Stock Units Options Exercise -1,548 -100% 0 03 Aug 2023 Common Stock 1,548 Direct F1, F4
transaction FIXX Restricted Stock Units Options Exercise -387 -100% 0 03 Aug 2023 Common Stock 387 Direct F1, F4
transaction FIXX Restricted Stock Units Options Exercise -4,644 -100% 0 03 Aug 2023 Common Stock 4,644 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Julie Jordan is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.
F2 The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction entered into on May 27, 2022 solely with the intent to cover taxes in connection with the vesting of certain previously reported restricted stock units.
F3 The sales reported in the Form 4 were effected pursuant to a mandatory sell to cover arrangement solely with the intent to cover taxes in connection with the vesting of certain previously reported restricted stock units.
F4 Vesting for a portion of the restricted stock units was accelerated and such portion vested and settled on August 3, 2023. The restricted stock units would otherwise have vested and settled as to one half of the restricted stock units on each of January 1, 2024 and January 1, 2025. The remaining restricted stock units have been automatically cancelled and forfeited.
F5 Vesting for a portion of the restricted stock units was accelerated and such portion vested and settled on August 3, 2023. The restricted stock units would otherwise have vested and settled as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2023 so that such restricted stock units would have become fully vested on January 1, 2026. The remaining restricted stock units have been automatically cancelled and forfeited.